U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
119371119371Gene Therapy for the Treatment of Chronic Stable AnginaWithdrawnNo Results AvailableMyocardial IschemiaGenetic: VM202https://ClinicalTrials.gov/show/NCT01002495
119372119372Computerized Glucose Control in Critically Ill PatientsCompletedHas ResultsHyperglycemia|Critical IllnessDevice: CGAO-based Glucose Control|Device: Standard-Care Glucose Controlhttps://ClinicalTrials.gov/show/NCT01002482
119373119373Study to Evaluate 13 C Isotope Ratio Measurement for Urea Cycle Capacity AssessmentCompletedNo Results AvailableUrea Cycle DisordersOther: sodium [1-13C] acetatehttps://ClinicalTrials.gov/show/NCT01002469
119374119374Beta-Blockers in Heart Failure: Pharmacy-level Intervention ComparisonCompletedHas ResultsHeart FailureOther: Level 1: (provide site-specifi information)|Other: Level 2 (Provide site- and patient-specific information)https://ClinicalTrials.gov/show/NCT01002456
119375119375Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric CancerCompletedNo Results AvailableGastric CancerDrug: Helicobacter pylori eradication|Drug: placebohttps://ClinicalTrials.gov/show/NCT01002443
119376119376EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart DiseaseActive, not recruitingNo Results AvailableAngina Pectoris|Myocardial InfarctionBiological: VEGF-D gene transferhttps://ClinicalTrials.gov/show/NCT01002430
119377119377MCS in the Treatment of Lower Urinary Tract SymptomsCompletedNo Results AvailableLower Urinary Tract Symptoms|Benign Prostatic HyperplasiaDrug: MCS-2 15 mg/day|Drug: MCS-2 30 mg/day|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01002417
119378119378The Use of Guide Wire in Biliary Cannulation: Angled or Straight Tipped Guide Wire?CompletedNo Results AvailableDeep Biliary CannulationProcedure: angled and straight tipped guide wirehttps://ClinicalTrials.gov/show/NCT01002404
119379119379Dressing Wear Time After Reduction MammaplastyCompletedNo Results AvailableSurgical Site Infection|Skin ColonizationProcedure: reduction mammaplasty|Procedure: reduction mammaplastyhttps://ClinicalTrials.gov/show/NCT01002391
119380119380The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of RegorafenibCompletedNo Results AvailableDietary Fats|PharmacokineticsDrug: Regorafenib (Stivarga, BAY73-4506)|Drug: Regorafenib (Stivarga, BAY73-4506)|Drug: Regorafenib (Stivarga, BAY73-4506)https://ClinicalTrials.gov/show/NCT01002378
119381119381Perioperative Hyperoxygenation and Wound Site Infection Following Surgery for Acute AppendicitisCompletedNo Results AvailableAcute AppendicitisOther: Oxygen delivery|Other: Oxygen administrationhttps://ClinicalTrials.gov/show/NCT01002365
119382119382Bariatric Outcomes Longitudinal Database (BOLD)Active, not recruitingNo Results AvailableObesity|Overweight|Diabeteshttps://ClinicalTrials.gov/show/NCT01002352
119383119383Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After TransplantationTerminatedNo Results AvailableDiabetes Mellitus, Adult-OnsetDrug: Tacrolimus with rapid steroid withdrawal|Drug: Tacrolimus with steroids minimization|Drug: CsA with steroid minimizationhttps://ClinicalTrials.gov/show/NCT01002339
119384119384Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic DisorderActive, not recruitingNo Results AvailableBody Dysmorphic DisorderBehavioral: Cognitive-Behavioral Therapyhttps://ClinicalTrials.gov/show/NCT01002326
119385119385Effect of Prednisone onTregs and TH17CompletedNo Results AvailableChronic Rhinosinusitishttps://ClinicalTrials.gov/show/NCT01002313
119386119386Oxytocin and Social Cognition in Frontotemporal DementiaCompletedNo Results AvailableFrontotemporal Dementia|Pick's DiseaseDrug: intranasal oxytocinhttps://ClinicalTrials.gov/show/NCT01002300
119387119387An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal SurgeryTerminatedHas ResultsUlcerative Colitis|Familial PolyposisDevice: SprayShield Adhesion Barrier System|Procedure: Good Surgical Technique Alonehttps://ClinicalTrials.gov/show/NCT01002287
119388119388Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract SymptomsCompletedNo Results AvailableLower Urinary Tract Symptoms|Benign Prostatic HyperplasiaDrug: MCS-2https://ClinicalTrials.gov/show/NCT01002274
119389119389Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy SubjectsCompletedNo Results AvailableLiver Cirrhosishttps://ClinicalTrials.gov/show/NCT01002261
119390119390Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma PatientsTerminatedNo Results AvailableMultiple MyelomaDrug: Perifosine|Drug: Perifosine Placebo|Drug: Bortezomib|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT01002248
119391119391Gene Therapy for Painful Diabetic NeuropathyCompletedNo Results AvailablePainful Diabetic NeuropathyGenetic: VM202https://ClinicalTrials.gov/show/NCT01002235
119392119392Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)CompletedNo Results AvailableLower Urinary Tract Symptoms|Benign Prostatic HyperplasiaDrug: MCS-2https://ClinicalTrials.gov/show/NCT01002222
119393119393Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular SurgeryRecruitingNo Results AvailableDiabetes|Peripheral Arterial Disease|Arterial Occlusive DiseaseProcedure: Hyperbaric Oxygen treatment (HBO)|Procedure: Sham HBOhttps://ClinicalTrials.gov/show/NCT01002209
119394119394Randomised Controlled Treatment Study of Selective MutismCompletedNo Results AvailableSelective MutismBehavioral: Stimulus fading procedures|Behavioral: Guidance on defocused communicationhttps://ClinicalTrials.gov/show/NCT01002196
119395119395Fosmidomycin With Clindamycin or With Clindamycin Plus ArtesunateWithdrawnNo Results AvailableMalariaDrug: Fosmidomycinhttps://ClinicalTrials.gov/show/NCT01002183
119396119396Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis MedicamentCompletedNo Results AvailablePulmonary Tuberculosishttps://ClinicalTrials.gov/show/NCT01002170
119397119397The Effects of Vitamin K2 Supplementation on the Progression of Coronary Artery CalcificationRecruitingNo Results AvailableCoronary Artery DiseaseDietary Supplement: Menaquinone-7 (Vitamin K2)|Other: Placebo capsuleshttps://ClinicalTrials.gov/show/NCT01002157
119398119398C-Reactive Protein as a Predictor for Airway Hyper-ResponsivenessCompletedNo Results AvailableAsthmaOther: blood samplinghttps://ClinicalTrials.gov/show/NCT01002144
119399119399Exact Localisation of Impacted and Supernumerary Teeth by Cone Beam Computer Tomography (CT)CompletedNo Results AvailableImpacted TeethDevice: CBCThttps://ClinicalTrials.gov/show/NCT01002131
119400119400Feasibility Study of Omega-3 Fatty Acids in Dialysis PatientsRecruitingNo Results AvailableCardiovascular DiseaseDrug: Omega-3 Acid Ethyl Esters|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01002118

* Görseller ve İçerik tekif hakkına sahip olabilir